MSB 1.04% $1.46 mesoblast limited

Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-381

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,344 Posts.
    lightbulb Created with Sketch. 959
    Timmy and others who post on vrs37 , He/She has a degree in oncology and gastroenterology medicine And my guess views Stem cells as an alternative medicine , not what he/she spent many years studying, which I can understand . Change is always looked upon as the inferior method but we must move with it to improve the new technology for the better and in this case change the paradigm of medicine , which is going to happen ...
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.